As glucose levels fall and your insulin needs drop, GLP-1 agonists stop stimulating the production of the hormone
"As the use of these medications continues to expand worldwide, understanding their broader implications in men's health will become increasingly important, he concluded
Proper candidate screening, gradual dose escalation, hydration monitoring, and periodic labs mitigate these risks
Phase II clinical trials showed that participants using retatrutide lost 17.5% of their weight after 24 weeks and 24.2% after 48 weeks
Lysophagy, Golgiphagy and nucleophagy are emerging pathways of selective autophagy that could potentially have roles in stress responses that are relevant to the kidney
About 43% of companies with 5,000+ employees cover GLP-1s for weight loss, compared to 30% of large employers (1,000-4,999) and 16% of mid-size employers (200-999)